{"id":23812,"date":"2012-07-20T12:51:17","date_gmt":"2012-07-20T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23812"},"modified":"2018-04-14T02:07:38","modified_gmt":"2018-04-14T07:07:38","slug":"23812","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23812\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 20 de julho de 2012"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN_7-20-12.pdf\">vers\u00e3o para impress\u00e3o<\/a><\/p>\n<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <br \/>\nNot\u00edcias e notas sobre sa\u00fade animal de 20 de julho de 2012<\/strong><br \/>\nCopyright \u00a9 Brakke Consulting, Inc.<br \/>\n&nbsp;<br \/>\nEditor: Lynn Fondon DVM MBA<br \/>\n************************************<br \/>\nNAS NOTICIAS:<br \/>\n&nbsp;<br \/>\n<u>not\u00edcias de Brakke<br \/>\n<\/u>Novo estudo: Pr\u00e1tica de Animais de Companhia em 2017 e 2022<br \/>\n&nbsp;<br \/>\n<u>not\u00edcias de ganhos<br \/>\n<\/u>IDEXX<br \/>\nVetoquinol<br \/>\nVirbac<br \/>\n&nbsp;<br \/>\n<u>outras not\u00edcias<\/u><br \/>\nbimeda<br \/>\nIDEXX<br \/>\nNovartis<br \/>\nTeva<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n<strong>BRAKKE CONSULTING, INC.<br \/>\nNOVO ESTUDO LAN\u00c7ADO:<br \/>\nA Pr\u00e1tica de Animais de Companhia em 2017 e 2022<\/strong><br \/>\n&nbsp;<br \/>\nComo ser\u00e3o as cl\u00ednicas de animais de companhia em 2017 e 2022? Como essas mudan\u00e7as impactar\u00e3o a presta\u00e7\u00e3o de cuidados veterin\u00e1rios aos donos de animais de estima\u00e7\u00e3o? \u00c0 medida que a opera\u00e7\u00e3o e a propriedade das cl\u00ednicas de animais de companhia evoluem nos pr\u00f3ximos anos, as empresas que fornecem produtos e servi\u00e7os poder\u00e3o necessitar de alterar os seus pressupostos operacionais.<\/p>\n<p>Este novo estudo de mercado abrangente da Brakke Consulting, \u201cA Pr\u00e1tica de Animais de Companhia em 2017 e 2022: Uma Vis\u00e3o do Futuro\u201d espera fornecer as respostas a estas e outras quest\u00f5es, fornecendo uma an\u00e1lise das atuais tend\u00eancias convergentes na profiss\u00e3o de animais de companhia e nos propriet\u00e1rios de animais de estima\u00e7\u00e3o. utiliza\u00e7\u00e3o de servi\u00e7os veterin\u00e1rios. O estudo ir\u00e1 resumir e projectar as potenciais implica\u00e7\u00f5es destas tend\u00eancias para os prestadores.<\/p>\n<p>O estudo estar\u00e1 dispon\u00edvel no in\u00edcio de 2013. Para pr\u00e9-adquirir esta importante ferramenta de planejamento estrat\u00e9gico, ou para obter mais informa\u00e7\u00f5es, entre em contato com Ron Brakke em <a href=\"mailto:RBrakke@Brakkeconsulting.com\">RBrakke@Brakkeconsulting.com<\/a> ou Susan Warren em <a href=\"mailto:SWarren@BrakkeConsulting.com\">SWarren@BrakkeConsulting.com<\/a> .<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\nRELEASES DE RESULTADOS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; Virbac reportou resultados para o segundo trimestre de 2012. As vendas consolidadas no segundo trimestre atingiram 173 milh\u00f5es de euros ($212 milh\u00f5es), uma varia\u00e7\u00e3o de 12% em compara\u00e7\u00e3o com o mesmo per\u00edodo de 2011. As vendas aumentaram 9% excluindo impactos de taxas de c\u00e2mbio favor\u00e1veis e 10% a taxas constantes. escopo. (site da companhia)<br \/>\n&nbsp;<br \/>\n&gt; A Vetoquinol anunciou os resultados do primeiro semestre de 2012. As vendas atingiram 146,8 milh\u00f5es de euros ($180 milh\u00f5es), um aumento de 5% em rela\u00e7\u00e3o ao primeiro semestre de 2011. Em moeda constante, as receitas do primeiro semestre de 2012 cresceram 4% e o crescimento org\u00e2nico chegou a 2% durante o per\u00edodo. Os segmentos pet e pecu\u00e1rio cresceram 8% e 3% respectivamente. (site da companhia)<br \/>\n&nbsp;<br \/>\n&gt; IDEXX Laboratories, Inc. divulgou resultados para o segundo trimestre de 2012. As receitas aumentaram 6% para $335,6 milh\u00f5es em compara\u00e7\u00e3o com o segundo trimestre de 2011. O crescimento org\u00e2nico da receita1 foi de 7%. As receitas do Companion Animal Group (\u201cCAG\u201d) no segundo trimestre de 2012 foram de $278,3 milh\u00f5es, e um aumento de 7% em compara\u00e7\u00e3o com o segundo trimestre de 2011. (site da empresa) <br \/>\n&nbsp;<br \/>\n************************************<br \/>\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Novartis anunciou a conclus\u00e3o de um novo laborat\u00f3rio de aquicultura de \u00faltima gera\u00e7\u00e3o na Ilha do Pr\u00edncipe Eduardo (PEI), no Canad\u00e1. O novo centro de pesquisa $2,8 milh\u00f5es em PEI faz parte da divis\u00e3o de sa\u00fade aqu\u00e1tica. (Farm\u00e1cia Animal) <br \/>\n&nbsp;<br \/>\n&gt; Bimeda anunciou a aquisi\u00e7\u00e3o de cinco produtos ANADA da Teva Animal Health, Inc. Os produtos incluem Cloridrato de Levamisol em P\u00f3 para Drench, Cloridrato de Levamisol Sol\u00favel para Vermes Su\u00ednos, Cloridrato de Oxitetraciclina 10g em P\u00f3, Cloridrato de Oxitetraciclina 343g em P\u00f3 e Griseofulvina em P\u00f3. A empresa planeja relan\u00e7ar os produtos como itens da marca Bimeda com novos nomes comerciais. Os termos financeiros n\u00e3o foram divulgados. (Vantagem veterin\u00e1ria) <br \/>\n&nbsp;<br \/>\n&gt; Os Laborat\u00f3rios IDEXX anunciaram o lan\u00e7amento do relat\u00f3rio de resultados de diagn\u00f3stico IDEXX VetConnect PLUS. Este novo servi\u00e7o permite que os veterin\u00e1rios vejam, em uma tela, todo o hist\u00f3rico de exames de sangue de um paciente, gerado pelos equipamentos de ponto de atendimento e laborat\u00f3rios de refer\u00eancia da IDEXX. O hist\u00f3rico de trabalho laboratorial do paciente pode ser visualizado em um desktop, laptop, tablet ou smartphone. (site da companhia) <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL<br \/>\n&nbsp;<br \/>\n&gt; TAIWAN \u2013 GRIPE AVI\u00c1RIA As autoridades veterin\u00e1rias de Taiwan relataram um surto de gripe avi\u00e1ria altamente patog\u00eanica. O surto foi causado pela movimenta\u00e7\u00e3o ilegal de aves; 38 aves foram interceptadas no Aeroporto Internacional de Taiwan Taoyuan no in\u00edcio deste m\u00eas. Das 38 aves suscept\u00edveis, foram notificados 37 casos. Todas as 38 aves foram destru\u00eddas. (Farm\u00e1cia Animal)<br \/>\n&nbsp;<br \/>\n&gt; MUNDO \u2013 FEBRE AFTICA Um importante acad\u00e9mico de sa\u00fade veterin\u00e1ria do Reino Unido calculou que os custos globais anuais totais da febre aftosa (FA) rondam actualmente os $5 mil milh\u00f5es. O Dr. Jonathan Rushton disse que o impacto financeiro da febre aftosa pode ser separado em dois componentes: perdas diretas, devido a uma redu\u00e7\u00e3o na produ\u00e7\u00e3o e mudan\u00e7as na estrutura do rebanho; e perdas indirectas relacionadas com os custos significativos do controlo e gest\u00e3o da febre aftosa, al\u00e9m do fraco acesso aos mercados e da utiliza\u00e7\u00e3o limitada de tecnologias de produ\u00e7\u00e3o melhoradas. (Farm\u00e1cia Animal)<br \/>\n&nbsp;<br \/>\n************************************<br \/>\nPONTO DE VISTA DA BRAKKE CONSULTORIA<\/p>\n<p>Uau!! Que diferen\u00e7a tr\u00eas semanas de temperaturas acima de 100 graus e nenhuma chuva podem fazer para a comunidade agr\u00edcola. Os futuros do mercado de cereais dispararam devido ao impacto das condi\u00e7\u00f5es de seca no Cintur\u00e3o do Milho e noutras partes dos EUA. Em algumas \u00e1reas do pa\u00eds, as pastagens e o abastecimento de \u00e1gua passaram de abundantes para desesperadamente baixos. Isso poderia resultar em muitos bovinos indo para os confinamentos mais cedo e em mais liquida\u00e7\u00e3o de rebanhos, continuando a tend\u00eancia iniciada no ano passado. H\u00e1 apenas algumas semanas pens\u00e1vamos que talvez j\u00e1 tiv\u00e9ssemos superado a seca de 2012. Os elevados pre\u00e7os das mat\u00e9rias-primas poderiam acrescentar aspectos negativos a uma economia j\u00e1 fraca. Esperemos que comece a chover e esfriar mais cedo ou mais tarde.<\/p>\n<p>Anteriormente nas not\u00edcias, informamos o lan\u00e7amento de nosso novo estudo, \u201cA pr\u00e1tica dos animais de companhia em 2017 e 2022: uma vis\u00e3o do futuro\u201d. Este estudo \u00e9 o produto de conversas que tivemos nos \u00faltimos meses com v\u00e1rios executivos seniores do setor. Uma das perguntas que nos fazem com mais frequ\u00eancia \u00e9 \u201ccomo voc\u00ea acha que ser\u00e3o os nossos clientes veterin\u00e1rios de animais de companhia daqui a 5 ou 10 anos?\u201d Acreditamos que a Brakke Consulting tem a experi\u00eancia e os insights para responder a estas e outras quest\u00f5es que est\u00e3o na mente dos nossos clientes enquanto planeiam as suas organiza\u00e7\u00f5es e estrat\u00e9gias para o futuro. Aguardamos a sua participa\u00e7\u00e3o neste novo estudo.<\/p>\n<p>Tenha um \u00f3timo final de semana e fique tranquilo!!<\/p>\n<p>Ron Brakke<br \/>\n&nbsp;<br \/>\n************************************<br \/>\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.<br \/>\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em <a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke Consulting, Inc.<br \/>\n12005 Ford Rd., Suite 530<br \/>\nDallas, TX 75234 EUA<\/p>","protected":false},"excerpt":{"rendered":"<p>vers\u00e3o para impress\u00e3o ************************************ Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 20 de julho de 2012 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Not\u00edcias da Brakke Novo estudo: Pr\u00e1tica de animais de companhia em 2017 e 2022 not\u00edcias sobre lucros IDEXX Vetoquinol Virbac outras not\u00edcias Bimeda IDEXX Novartis Teva ************************************ BRAKKE CONSULTING, INC. NOVO ESTUDO LAN\u00c7ADO: A pr\u00e1tica de animais de companhia em 2017 e 2022 Como ser\u00e3o as cl\u00ednicas de animais de companhia em 2017 e 2022? Como essas mudan\u00e7as impactar\u00e3o a presta\u00e7\u00e3o de cuidados veterin\u00e1rios aos donos de animais de estima\u00e7\u00e3o? \u00c0 medida que a opera\u00e7\u00e3o e a propriedade das cl\u00ednicas de animais de companhia evoluem nos pr\u00f3ximos anos, as empresas que fornecem produtos e servi\u00e7os podem precisar mudar suas premissas operacionais. Este novo estudo de mercado abrangente da Brakke Consulting, \u201cThe Companion Animal Practice in 2017 and 2022: A View of the Future\u201d espera fornecer as respostas para essas e outras perguntas, fornecendo uma an\u00e1lise das tend\u00eancias convergentes atuais na profiss\u00e3o de animais de companhia e na utiliza\u00e7\u00e3o de servi\u00e7os veterin\u00e1rios por donos de animais de estima\u00e7\u00e3o. O estudo resumir\u00e1 e projetar\u00e1 as implica\u00e7\u00f5es potenciais dessas tend\u00eancias para os provedores. O estudo estar\u00e1 dispon\u00edvel no in\u00edcio de 2013. Para pr\u00e9-comprar esta importante ferramenta de planejamento estrat\u00e9gico, ou para mais informa\u00e7\u00f5es, entre em contato com Ron Brakke em RBrakke@Brakkeconsulting.com ou Susan Warren em SWarren@BrakkeConsulting.com. www.BrakkeConsulting.com &nbsp;<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/23812\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23812","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23812\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for July 20, 2012 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke news New study: Companion Animal Practice in 2017 &amp; 2022 &nbsp; earnings news IDEXX Vetoquinol Virbac &nbsp; other news Bimeda IDEXX Novartis Teva &nbsp; *********************************** BRAKKE CONSULTING, INC. NEW STUDY LAUNCHED: The Companion Animal Practice in 2017 and 2022 &nbsp; What will companion animal clinics look like in 2017 and 2022? How will these changes impact the delivery of veterinary care to pet owners? As the operation and ownership of companion animal clinics evolves over the coming years, the companies providing products and services may need to change their operational assumptions. This new Brakke Consulting&rsquo;s comprehensive market study, &ldquo;The Companion Animal Practice in 2017 and 2022: A View of the Future&rdquo; hopes to provide the answers to these and other questions by providing an analysis of current converging trends in the companion animal profession and pet owner utilization of veterinary services. The study will summarize and project the potential implications of these trends for providers. The study will be available in early 2013. To pre-purchase this important strategic planning tool, or for more information, contact Ron Brakke at RBrakke@Brakkeconsulting.com or Susan Warren at SWarren@BrakkeConsulting.com . &nbsp; www.BrakkeConsulting.com &nbsp;View Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23812\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2012-07-20T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:07:38+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23812\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23812\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for July 20, 2012\",\"datePublished\":\"2012-07-20T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:07:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23812\/\"},\"wordCount\":994,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23812\/\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/23812\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2012-07-20T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:07:38+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23812\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/pt\/23812\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23812\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for July 20, 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23812\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for July 20, 2012 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke news New study: Companion Animal Practice in 2017 &amp; 2022 &nbsp; earnings news IDEXX Vetoquinol Virbac &nbsp; other news Bimeda IDEXX Novartis Teva &nbsp; *********************************** BRAKKE CONSULTING, INC. NEW STUDY LAUNCHED: The Companion Animal Practice in 2017 and 2022 &nbsp; What will companion animal clinics look like in 2017 and 2022? How will these changes impact the delivery of veterinary care to pet owners? As the operation and ownership of companion animal clinics evolves over the coming years, the companies providing products and services may need to change their operational assumptions. This new Brakke Consulting&rsquo;s comprehensive market study, &ldquo;The Companion Animal Practice in 2017 and 2022: A View of the Future&rdquo; hopes to provide the answers to these and other questions by providing an analysis of current converging trends in the companion animal profession and pet owner utilization of veterinary services. The study will summarize and project the potential implications of these trends for providers. The study will be available in early 2013. To pre-purchase this important strategic planning tool, or for more information, contact Ron Brakke at RBrakke@Brakkeconsulting.com or Susan Warren at SWarren@BrakkeConsulting.com . &nbsp; www.BrakkeConsulting.com &nbsp;View Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23812\/","og_site_name":"Brakke Consulting Website","article_published_time":"2012-07-20T17:51:17+00:00","article_modified_time":"2018-04-14T07:07:38+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/pt\/23812\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/pt\/23812\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for July 20, 2012","datePublished":"2012-07-20T17:51:17+00:00","dateModified":"2018-04-14T07:07:38+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/pt\/23812\/"},"wordCount":994,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/pt\/23812\/","url":"https:\/\/brakkeconsulting.com\/pt\/23812\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2012-07-20T17:51:17+00:00","dateModified":"2018-04-14T07:07:38+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/pt\/23812\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/pt\/23812\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/pt\/23812\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for July 20, 2012"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23812"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23812\/revisions"}],"predecessor-version":[{"id":25296,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23812\/revisions\/25296"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}